Smith, LauraSaganty, JohnForget, Patrice2024-08-062024-08-062024-10Smith, L, Saganty, J & Forget, P 2024, 'Biomarkers in the Immuno-oncology Interface of Triple Negative Breast Cancer : A Scoping Review with Perioperative Considerations', Current Oncology Reports, vol. 26, no. 10, pp. 1159–1168. https://doi.org/10.1007/s11912-024-01572-z1534-6269ORCID: /0000-0001-5772-8439/work/163080493https://hdl.handle.net/2164/23977Conflicts of Interest PF received advisory board/speaker fees from Grunenthal, GE Healthcare and Oncomfort. LS and JS have no con- flicts of interest to declare. Human and Animal Rights This article does not contain any studies with human or animal subjects performed by any of the authors.10632673engSDG 3 - Good Health and Well-beingBiomarkersImmunotherapyOutcomesPerioperativeTriple negative breast cancerR Medicine (General)OncologyR1Journal article10.1007/s11912-024-01572-z2610